Asker Healthcare Group’s Post

Attention UK MedTech suppliers You’ve got 13 days to make a difference The Cabinet Office is seeking your views on key procurement guidelines - and you have 13 days to respond. Here's what you need to know: • The consultation concerns changes to the National Procurement Policy Statement (NPPS) • Deadline for comments: 4th November 2024 • Implementation of new guidelines: February 2025 There are 4 key focus areas: 1. Maximising value for money 2. Delivering social value 3. Enabling collaboration 4. Fostering innovation These changes could affect how NHS trusts and other public bodies procure MedTech products, and a great chance to advocate for Value Based Procurement. You’ll also be able to voice concerns about reforms to Part IX of the Drug Tariff. Here’s how to contribute: 1. Review the consultation questions 2. Gather input from your team 3. Prepare and submit your response before the deadline If you need help finding public sector opportunities in MedTech, check out our site: https://lnkd.in/dgbWvwTw 

Here's a very informative post on clinical trial equipment supply, how it has adapted post-Brexit, and progression into APAC regions.

The new medical device (MD) procurement policy in Hong Kong will enter its Phase II from 1 November 2024, where all MDs in quotations submitted to the Department of Health (DH) must have either: - already been approved (listed under the Medical Device Administrative Control System) or - been granted a listing application number (under review by the regulator).   It is expected that by 2025, only listed MDs will be accepted by DH.   This is an enhancement of the Phase I strategy implemented in June 2023 where “listed MDs” were “given preference” in the tender/bid/quotation process in Hong Kong. Given that the public healthcare sector makes up a much larger proportion of the healthcare system compared to private healthcare providers in Hong Kong, this 2nd phase signifies that the device approval process is moving from a “voluntary” to “almost mandatory” system in 2025.    Contact #PharmaLex if you have any query relating to your #HongKong approvals. https://lnkd.in/gY8hyzEr https://lnkd.in/g7DnaCF5

COREX Logistics is Barcelona-bound for the Clinical Trial Supply Europe 2024! Bringing our wealth of expertise in Procurement, Early Access Programs, International & Local Logistics, and Temperature-Controlled Shipments, we're here to solve any logistical puzzle you might be facing. Looking for insights and best practices? Our logistics expert, Steve Healy, can't wait to share his knowledge and help you navigate the complexities of clinical trial supply chain management. 📅 Book a meeting with Steve Healy at the event to dive deeper into how we can enhance your logistics strategy. Secure your slot here: https://lnkd.in/ed9BmcRy Let's connect and explore how we can elevate your logistics strategy to the next level. See you there! #CTS2024 #Logistics #SupplyChain

Europe E-Pharmacy Market Outlook & Forecast Report 2023-2028: How Strategic Acquisitions & Technology Integration is Re-Shaping the Multi-Billion Industry

Our latest Antitrust in focus examines a number of major merger control developments - revised U.S. filing forms, new U.K. thresholds and a remedies review, progress towards Australia’s mandatory regime and further EU scrutiny of below-threshold deals. The life sciences sector is also in the spotlight, with the landmark EC ruling against Teva and continued U.S. scrutiny of healthcare M&A. And we give you the latest in the EU saga over Intel’s rebates. Read more here: https://lnkd.in/ecvEHRr5

Maintaining CRO-vendor relationships is tough but crucial for success. To navigate these challenges, Our Vice President of Global Partnerships, Anthony Encarnacao, shares a four-step checklist for #CROs to build lasting relationships. Check out Suvoda’s latest blog to learn more!

Go #KangarooOMNI! The future of Enteral Feeding is HERE! Excited to share more about our passion in supporting enteral-fed patients and physicians along the enteral feeding journey! #HydrationMatters #Byyoursideandbeyond #KangarooOMNI

How did you choose your company name? Is there a company name that has impressed you? Check this out about the meaning behind my company's name.👇